Form 8-K - Current report:
SEC Accession No. 0001558370-25-009739
Filing Date
2025-07-29
Accepted
2025-07-29 16:15:18
Documents
44
Period of Report
2025-07-29
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acrs-20250729x8k.htm   iXBRL 8-K 41439
2 EX-99.1 acrs-20250729xex99d1.htm EX-99.1 42636
3 EX-99.2 acrs-20250729xex99d2.htm EX-99.2 34898
4 GRAPHIC acrs-20250729xex99d1g001.jpg GRAPHIC 117419
5 GRAPHIC acrs-20250729xex99d1g002.jpg GRAPHIC 302840
6 GRAPHIC acrs-20250729xex99d1g003.jpg GRAPHIC 100277
7 GRAPHIC acrs-20250729xex99d1g004.jpg GRAPHIC 153122
8 GRAPHIC acrs-20250729xex99d1g005.jpg GRAPHIC 118768
9 GRAPHIC acrs-20250729xex99d1g006.jpg GRAPHIC 119595
10 GRAPHIC acrs-20250729xex99d1g007.jpg GRAPHIC 104097
11 GRAPHIC acrs-20250729xex99d1g008.jpg GRAPHIC 113113
12 GRAPHIC acrs-20250729xex99d1g009.jpg GRAPHIC 101534
13 GRAPHIC acrs-20250729xex99d1g010.jpg GRAPHIC 81909
14 GRAPHIC acrs-20250729xex99d1g011.jpg GRAPHIC 125394
15 GRAPHIC acrs-20250729xex99d1g012.jpg GRAPHIC 118161
16 GRAPHIC acrs-20250729xex99d1g013.jpg GRAPHIC 124964
17 GRAPHIC acrs-20250729xex99d1g014.jpg GRAPHIC 119493
18 GRAPHIC acrs-20250729xex99d1g015.jpg GRAPHIC 156671
19 GRAPHIC acrs-20250729xex99d1g016.jpg GRAPHIC 136458
20 GRAPHIC acrs-20250729xex99d1g017.jpg GRAPHIC 101745
21 GRAPHIC acrs-20250729xex99d1g018.jpg GRAPHIC 107572
22 GRAPHIC acrs-20250729xex99d1g019.jpg GRAPHIC 138655
23 GRAPHIC acrs-20250729xex99d1g020.jpg GRAPHIC 118703
24 GRAPHIC acrs-20250729xex99d1g021.jpg GRAPHIC 111257
25 GRAPHIC acrs-20250729xex99d1g022.jpg GRAPHIC 136022
26 GRAPHIC acrs-20250729xex99d1g023.jpg GRAPHIC 119971
27 GRAPHIC acrs-20250729xex99d1g024.jpg GRAPHIC 113486
28 GRAPHIC acrs-20250729xex99d1g025.jpg GRAPHIC 174978
29 GRAPHIC acrs-20250729xex99d1g026.jpg GRAPHIC 71355
30 GRAPHIC acrs-20250729xex99d1g027.jpg GRAPHIC 119625
31 GRAPHIC acrs-20250729xex99d1g028.jpg GRAPHIC 117419
32 GRAPHIC acrs-20250729xex99d2001.jpg GRAPHIC 8678
33 GRAPHIC acrs-20250729xex99d2002.jpg GRAPHIC 12836
  Complete submission text file 0001558370-25-009739.txt   5078940

Data Files

Seq Description Document Type Size
34 EX-101.SCH acrs-20250729.xsd EX-101.SCH 3462
35 EX-101.LAB acrs-20250729_lab.xml EX-101.LAB 15916
36 EX-101.PRE acrs-20250729_pre.xml EX-101.PRE 10223
46 EXTRACTED XBRL INSTANCE DOCUMENT acrs-20250729x8k_htm.xml XML 4840
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 251162054
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)